U S PHYSICAL THERAPY INC /NV Quarterly Liabilities and Equity in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
U S Physical Therapy Inc /Nv quarterly Liabilities and Equity history and growth rate from Q4 2010 to Q2 2024.
  • U S Physical Therapy Inc /Nv Liabilities and Equity for the quarter ending June 30, 2024 was $1.02B, a 2.36% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.02B +$23.6M +2.36% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.02B +$149M +17.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $997M +$139M +16.2% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $1.01B +$210M +26.3% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1B +$203M +25.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $868M +$104M +13.7% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $858M +$109M +14.5% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $800M +$170M +26.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $796M +$173M +27.8% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $764M +$165M +27.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $749M +$155M +26.1% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $630M +$54.7M +9.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $623M +$37.9M +6.49% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $598M -$44.9M -6.97% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $594M +$33.5M +5.98% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $575M +$10.2M +1.81% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $585M +$28M +5.03% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $643M +$120M +23% Mar 31, 2020 10-Q 2020-05-21
Q4 2019 $561M +$118M +26.6% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $565M +$110M +24.2% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $557M +$116M +26.4% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $523M +$105M +25.3% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $443M +$24.2M +5.77% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $455M +$44M +10.7% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $441M +$23.2M +5.56% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $418M +$30M +7.73% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 $419M +$67.8M +19.3% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $411M +$76.4M +22.9% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $417M +$79.3M +23.5% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $388M +$51.9M +15.5% Mar 31, 2017 10-Q 2017-06-29
Q4 2016 $351M +$47.5M +15.6% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $335M +$34.6M +11.5% Sep 30, 2016 10-K 2017-06-07
Q2 2016 $338M +$45.9M +15.7% Jun 30, 2016 10-K 2017-06-07
Q1 2016 $336M +$54.5M +19.4% Mar 31, 2016 10-K 2017-06-07
Q4 2015 $304M +$59.2M +24.2% Dec 31, 2015 10-K 2017-06-07
Q3 2015 $300M +$52.2M +21.1% Sep 30, 2015 10-K 2017-06-07
Q2 2015 $292M +$51.4M +21.3% Jun 30, 2015 10-K 2017-06-07
Q1 2015 $281M +$52.6M +23% Mar 31, 2015 10-K 2017-06-07
Q4 2014 $245M +$20.4M +9.11% Dec 31, 2014 10-K 2016-03-04
Q3 2014 $248M +$68.1M +37.9% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $241M +$58.4M +32% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $229M +$51.8M +29.3% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $224M +$52.4M +30.5% Dec 31, 2013 10-K 2015-03-12
Q3 2013 $180M +$9.72M +5.72% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $182M +$11.8M +6.91% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $177M +$12.4M +7.57% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $172M +$8.46M +5.18% Dec 31, 2012 10-K 2014-03-11
Q3 2012 $170M +$5.9M +3.6% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $171M +$23.8M +16.2% Jun 30, 2012 10-Q/A 2012-09-06
Q1 2012 $164M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $163M +$22.4M +15.9% Dec 31, 2011 10-K 2013-03-12
Q3 2011 $164M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $147M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 $141M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.